zidovudine has been researched along with Minimal Disease, Residual in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bangham, CRM; Cook, LB; Demontis, MA; Gillet, NA; Greiller, C; Melamed, A; Rowan, AG; Sagawe, S; Taylor, GP; Witkover, A | 1 |
1 other study(ies) available for zidovudine and Minimal Disease, Residual
Article | Year |
---|---|
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
Topics: Adult; Allografts; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm, Residual; Remission Induction; Time Factors; Zidovudine | 2018 |